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Treatment adherence among
tuberculosis patients
The main aim of this article is to provide insight into the determinants of treatment
adherence among pulmonary tuberculosis patients. The study was conducted at nine
clinics in the Free State province of South Africa. The quantitative evidence shows
that stigmatisation, the socio-economic circumstances of patients, and migrancy all
play important roles in explaining non-adherence. The qualitative evidence identi-
fied some of the factors affecting adherence as lack of knowledge about TB, the non-
sustainability of educational campaigns, the side-effects of drugs, hunger, lack of
family support, the stigma attached to TB, the attitude of health care workers and
the long delay before diagnosis. Based on this evidence, recommendations are made
for a number of provider-, patient- and community-centred interventions to improve
adherence.
Behandelingsnakoming van tuberkulose-pasiënte in die
Vrystaat, Suid-Afrika
Die hoofdoel van hierdie artikel is om insig te verskaf in die determinante wat ’n rol
speel in die nakoming van behandelingsinstruksies by pulmonêre tuberkulose pasiënte.
Die studie is onderneem by nege klinieke in die Vrystaat provinsie, Suid-Afrika. Die
kwantitatiewe bevindinge dui daarop dat stigma, die sosio-ekonomiese omstandig-
hede van die pasiënt en migrasie ’n belangrike rol speel by die verklaring van die nie-
nakoming van behandelingsinstruksies. Sommige van die waargenome faktore wat
die nakoming van behandelingsinstruksies beïnvloed, soos gebaseer op die kwalita-
tiewe bevindinge, sluit in gebrekkige kennis omtrent TB, die nievolhoubaarheid van
opvoedkundige programme, newe-effekte van medikasie, honger, gebrekkige gesins-
ondersteuning, die stigma gekoppel aan TB, die houding van gesondheidsorgwerkers
en die lang vertraging alvorens ’n diagnose gemaak word. Voortspruitend uit hierdie
bevindinge word aanbevelings gemaak rakende ’n aantal verskaffer-, pasiënt- en gemeen-
skapsgesentreerde intervensies wat die nakoming van behandelingsinstruksies kan
verbeter.
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According to Southern Africa Tuberculosis Control Initiative
1
(SATCI 2000: 2):
[T]uberculosis hardly needs any introduction. At least, not in Africa.
The debilitating bacteria of this curable, yet terminal disease, dic-
tate the lives of thousands of people in Southern Africa.
Globally, TB kills 5 000 people a day and more than 2.3 million a
year (WHO 2001: 1). More than 8 million people contract TB each
year, about 2 million of these in sub-Saharan Africa. This number is
rising rapidly as a result of the HIV/AIDS epidemic (Wilkinson 1999:
155). In South Africa, the long-term trends of TB (expressed by the
annual incidence rates from 1990 to 2001) are striking. It starts with
an incidence rate of 145/100 000 in 1990 (Van Rensburg et al 1992:
181), then displays a sustained and relatively sharp rise, reaching a
peak in 1998 with an incidence rate of 338/100 000, and an extre-
me high of 362/100 000 in 2001 (Dept of Health 2002a: 1).
Treatment outcomes — sometimes called patient outcomes —
including changes in patients’ current and future health status, are
considered the “end result” of health care provision (Wojner 2001: 6).
Against the background of increasing numbers of TB cases and poor
completion rates, in 1996 the National TB Control Programme in
1 This is an adapted version of a paper read at the conference Tuberculosis: A
multidisciplinary approach to research, policy and practice, C R Swart Audito-
rium, University of the Free State, Bloemfontein, 11-12 November 2004. In
essence, this study is part of a more comprehensive three-year study, the Joint
Research Project on Tuberculosis Control in the Free State, South Africa: From
Infection to Cure. This comprehensive study focuses on the “patient career”, the
socio-economic environment and the health care system. It is being conducted in
the context of the South African-Flemish Bilateral Scientific and Technological
Co-operation Programme.
The authors wish to thank the Free State Department of Health and the pro-
vincial and clinic TB co-coordinators for their support in this work. A special
word of appreciation is due to our Belgian colleagues whose unflagging dedica-
tion contributed to the success of the study. We are deeply indebted to the Fle-
mish government, the South African government, the National Research Foun-
dation, the Medical Research Council and the Anglo-American Chairman’s
Fund for having funded this research.
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South Africa adopted the World Health Organisation’s (WHO)
worldwide strategy of DOTS, or Directly Observed Treatment, Short
Course (Bamford 1999: 316). Effective treatment keeps patients from
dying of TB and prevents transmission to other members of society.
Treatment of active TB involves taking multiple anti-TB drugs for
five days a week, for at least six months (Rieder 2002: 10-1). The aim
of the DOTS strategy is two-fold. First, it aims at successful treat-
ment of 85% of detected smear-positive TB cases. Secondly, it aims to
detect 70% of such cases (WHO 2001: 3). This is to be achieved by
means of the five elements of the WHO’s DOTS strategy, namely
political commitment, laboratory improvement, direct observation of
treatment, improved drug supply, and improved reporting systems.
DOTS programmes often also encompass other interventions, such as
offering incentives and enablers to patients, tracing defaulters, using
legal sanctions to enforce adherence, adopting patient-centred ap-
proaches to health care delivery, motivating and supervising staff,
and raising additional external funding (cf Buchanan 1997; Jaramillo
1999; Volmink et al 2000). Therefore, DOTS involves much more
than just the direct supervision of tablet-taking, first introduced by
tuberculosis specialists more than 40 years ago (Volmink et al 2000).
In South Africa, TB treatment services are offered free of charge
at the primary level in public sector health care facilities, yet com-
pletion rates have been slow to improve. Many factors may lead to
poor adherence. On the surface, it appears that treatment outcomes
for TB patients are an indication of the quality of care they receive.
However, various authors have acknowledged that the complex inter-
actions of a wide range of personal, socio-economic, infrastructural
and community factors determine patient behaviour.2 As such, and
in terms of social learning theories, adherence is also a “function of
cues and consequences in the context of the social system” (Hovell et
al 2003: 1791). In fact, TB may not be cured and may recur if pa-
tients do not take their medication for the full treatment period. Such
patients may also become resistant to the drugs, and transmit drug-
2 Cf Farmer 1997; Pablos-Méndez et al 1997; Jaramillo 1999; Khan et al 2000;
Mata 1985; Meulemans et al 2000; Malotte et al 2001; Needham et al 2001;
Thorson 2001; Demissie et al 2003; Hovell et al 2003; Jaiswal et al 2003.
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resistant TB to others (Giuffrida & Togerson 1998: 189). Drug-
resistant TB is difficult and expensive to treat. Thus, the most im-
portant step in preventing drug-resistant disease is to ensure that pa-
tients are cured at the first attempt. This has provided a major impe-
tus for research into the study of factors that determine patients’
treatment adherence (Pablos-Méndez 1997). For perhaps the first time,
the world is facing a health threat to which the only effective
response is behavioural as well as medical (Cockerham 2001: 131).
Treatment outcomes in new smear-positive pulmonary tuberculosis
(PTB) patients in South Africa reveal that the cure rate nationally has
slowly improved from 56.6% in 1997 to 62.9% in 2000. However, the
cure rate in the Free State has shown a rapid increase from 49% in
1997 to 66% in 2000. Interruption rates remain high in the country,
however, despite slow decreases from 18.6% in 1997 to 15.8% in
2000. This perhaps explains the steady increase in the percentage of
pulmonary TB patients dying while on treatment (from 6.3% in
1997 to 8.3% in 2000). In 2000, the Free State had the third-highest
percentage of deaths (10.2%) after the Gauteng Province and Mpu-
malanga (Dept of Health 2002a: 1-3). Increased interruptions lead to
more serious illness among TB patients and to increased infectivity
within their communities (Needham et al 2001: 256). Clearly, improve-
ment is needed, especially within resource-poor settings such as the
Free State province. The purpose of this article is to identify factors
that explain adherence to treatment, or the lack thereof, among TB
patients in this province.3 Section 1 describes the research design and
methods employed. Sections 2 and 3 report the quantitative and qua-
3 In the recent literature the term “adherence” has come to be preferred to the
term “compliance” (first used in the 1960s), which has formed the basis of pro-
fessional discourse on the topic since the 1970s (Lerner 1997), since the latter
term has the “unfortunate connotation that the patient is docile and subservient
to the provider” (Volmink & Garner 1997: 1403). According to Farmer (1997:
349), the term “compliance” also “exaggerates patient agency, for it suggests
that all patients possess the ability to comply — or to refuse to comply — with
anti-tuberculosis therapies”. In this article, therefore, we use the terms adherence
and non-adherence, rather than compliance and non-compliance to describe
patient behaviour.
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litative evidence on determinants of adherence. The results are discussed
in section 4, while section 5 concludes with some recommendations.
1. Research design and methods
The study was conducted using a combination of quantitative and
qualitative research methods. Face-to-face interviews and focus group
discussions (FGDs) were conducted with pulmonary tuberculosis
patients at nine primary health care clinics. The study endeavoured to
recommend interventions at policy and practice levels. For this
reason, health care policy-makers were involved in the conceptualisa-
tion and design of the study. They are also part of the ongoing colla-
boration between the Centre for Health Systems Research & Deve-
lopment (CHSR&D) and the Free State Department of Health.
1.1 Study areas
The survey was conducted at nine primary health care clinics in three
geographical areas or health districts in the Free State province: Gold-
fields, a gold mining area; Qwaqwa, a previously “independent” black
homeland area, and Thaba Nchu, a typical small town in the vicinity
of a large African settlement (Van Rensburg & Redelinghuys 2001).
The areas were purposively selected to represent different regions of
the Free State, and to include rural and urban areas. Together, the se-
lected areas represent the broad spectrum of socio-economic and socio-
cultural variables impinging on TB patients’ treatment outcomes.
1.2 Population and sample
The population of the study was clinic-based pulmonary TB patients.
The patients interviewed at the clinic level were sampled on the basis
of a multistage design. A sampling frame — a list of clinics with a
high burden of PTB patients during the initial two quarters of 2001
— was obtained from the Department of Health.4 Thereafter, a stra-
tified random sample was utilised to ensure that specific characte-
ristics were represented. The sample was stratified according to the
4 The focus was on such clinics, due to the need to recruit as many patients as
possible for the study.
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category of patient, and patients were sampled in proportion to the
total number of each type of patient on the TB register at each clinic.5
Tuberculosis patients were stratified according to the following four
categories:
• new patient — intensive phase,
• new patient — continuation phase,
• re-treatment patient — intensive phase, and 
• re-treatment patient — continuation phase.





Type of re-treatment patient:
After previous cure
After previous treatment completion
After previous treatment interruption

















45 (37) 25 (25) 70 (32)





The study population comprised 220 pulmonary tuberculosis pa-
tients. Table 1 presents their characteristics by category and gender.
Fifty-five percent of patients interviewed were male and 45% female.
The majority of patients were new (68%), while almost a third were
re-treatment patients (32%). Of the latter, just more than half were
on re-treatment following a previous cure (53%), while just more than
a fifth (21%) were on re-treatment following treatment completion.
5 Visser et al (2000: 225) maintain that stratified sampling “provides greater con-
trol over the composition of the sample, assuring the researcher of representa-
tiveness of the sample in terms of the stratified variables”.
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* Including 3 pensioners
Total
For the sample of the FGDs, patients still on treatment were  ran-
domly selected from the TB registers in terms of their various illness
stages. FGDs were conducted with 7-8 participants at each of the
nine clinics. Those under the age of 16 and those who had been
treated for less than 2 months were excluded because they were per-
ceived to be “less experienced” about having TB. In total, 85 patients
participated in the FGDs. Table 2 presents their characteristics. Of
the 85 participants in the nine groups, 53% (n=45) were male. The
ages of the participants ranged from 18 to 57. The vast majority
(72%, n=61) were new patients (patients who had never been treated
for TB before), and only 8% (n=7) were employed. Thirty-six percent
indicated that they were living or had lived with someone who had
or had had TB before they were diagnosed as having the disease.
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1.3 Data collection and analysis
The Research Committee of the Faculty of the Humanities (UFS) ap-
proved the ethics of the study. Permission to conduct the survey was
also obtained from the Free State Department of Health and the
relevant district managers. The moderator, who is the first author of
this paper, telephonically informed the staff of the selected clinics of
the study. He also personally visited the clinics 3 days before the FGDs
to draw the sample and to make the necessary logistical arrange-
ments. All the participants gave informed consent for the interviews.
Structured, face-to-face interviews, guided by interview schedules,
were conducted with the 220 clinic patients. Five trained fieldwork-
ers conducted these interviews with the patients at the selected
clinics. Interviews were conducted in the language of the patients
and the completed questionnaires were edited immediately for qua-
lity assurance. Interviews lasted approximately an hour and were
conducted under difficult conditions, including the following:
• First, tuberculosis patients at certain clinics only took their me-
dication early in the morning. This constrained and complicated
the fieldwork logistics.
• Secondly, the non-availability of extra rooms at clinics forced
fieldworkers to conduct interviews with two or three patients in
one room.
• Thirdly, due to the long interview schedule, some patients asked
to be excused for a few minutes but never returned. In such in-
stances, interviews were conducted with patients on the reserve
sampling list.
• Lastly, the fieldwork manager not only had to provide support
and supervision to fieldworkers, but constantly also had to allay
their fears of contracting tuberculosis.
Data on the treatment outcomes of these patients were collected
from the tuberculosis registers at the clinics during October and No-
vember 2002.6 Bivariate analysis was used to compare adherent and
non-adherent patients in terms of certain key characteristics, including
socio-demographics and a number of possible determinants of adhe-
6 Complete outcomes data were missing for one patient.
  
rence. The Chi2 and t-tests were used to assess the statistical signifi-
cance of these differences in categorical variables and continuous va-
riables, respectively. Multiple logistic regression was employed in in-
vestigating the determinants of adherence, controlling for the possible
confounding effects of other variables. Data were analysed using SPSS
10.1 and Stata8 statistical software.
A moderator (the first author) and an experienced note-taker faci-
litated the nine focus group discussions (FGDs) during February
2003. Before each FGD session, the moderator welcomed the parti-
cipants and told them about the purpose of the FGD. The partici-
pants felt confident and at ease, and spoke freely as they already knew
one another. The sessions, which usually lasted one hour, were con-
ducted in the languages of the participants (Sotho and Tswana), and
taped-recorded with the participants’ consent. The FGDs began with
general questions before focusing on more specific questions as they
progressed (the funnel approach), using a topic guide to ensure that
the same areas were covered in each focus group. The questions co-
vered whether participants knew about TB before being diagnosed;
how or where they learned about TB; their knowledge of health edu-
cation campaigns, and perceived factors affecting adherence. The group
interaction allowed for a more in-depth understanding of patients’
beliefs about adherence than could have been gained from individual
interviews. The recordings were later transcribed and translated into
English. Another researcher who had not participated in the study
re-translated the English version for comparison, and the necessary
corrections were made. Field notes were written immediately after
each FGD.
2. Quantitative evidence on determinants of 
adherence
For the purpose of this analysis, adherence was defined as uninter-
rupted taking of prescribed medication. In terms of treatment outcomes,
adherence refers to successful outcomes and cases where treatment
was interrupted for at least two months. Successful outcomes include
cured patients who are smear negative at, or one month prior to, the
completion of treatment and on at least one previous occasion, as well
148
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as patients who have completed treatment, but whose smear results
are not available on at least two occasions prior to completion of treat-
ment.
Table 3: Patient treatment outcomes
Table 3 describes the treatment outcomes for the total study po-
pulation. This analysis, therefore, focuses on a comparison of the 173
patients with successful outcomes and the eleven patients who inter-
rupted their treatment (n=184), a sub-sample that constitutes almost
80% of the 220 patients interviewed in the study.
Table 4 reports the results of the bivariate analysis. The two groups
of patients are compared here in terms of a wide range of socio-demo-
graphic and household characteristics, as well as variables approxima-
ting the determinants of adherence expounded in the quantitative
literature.7 The descriptive statistics of these variables and the meaning
of index variables for the sub-sample of patients are described in de-
tail in Appendix 1.
7 Cf Farmer 1997; Pablos-Méndez et al 1997; Jaramillo 1999; Malotte et al 2001;























Note: Failed treatment refers to patients who remained or once again
became smear positive at five months or later during treatment.
Transferred out refers to patients transferred to another clinic, whose
treatment outcome is not known. Died refers to patients who died for
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Mean household size







91 (52.6) 10 (90.9)
82 (47.4) 1 (9.1) 0.013
37.7 42.7 0.077
66 (38.1) 5 (45.4)
107 (61.8) 6 (54.5) 0.629
132 (76.3) 9 (81.8)
29 (16.7) 1 (9.1)




9 (5.2) 0 (0.0) 0.437
50 (28.9) 7 (63.6) 0.016
1 (0.6) 1 (9.1) 0.008
64 (36.9) 5 (45.4) 0.574
58 (33.5) 5 (45.4) 0.419
25 (14.4) 2 (18.1) 0.735
1832 5415 0.075
25 28 0.346
15 (8.7) 3 (27.2) 0.045
0.1 0.3 0.008
16 (9.2) 4 (36.3) 0.005
158 (91.8) 10 (90.9) 0.911
141 (81.5) 11 (100.0) 0.117
156 (91.2) 10 (90.9) 0.971

















Mean years of education
Mean monthly household income (Rand)
Access to medical aid
Re-treatment patient




Income loss due to illness (Rand)
Travel time to clinic (minutes)
Away from home during treatment
Number of migrants in household
Ever in jail
Able to eat before taking tablets







Table 4: Comparison between adherent and non-adherent patients
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According to the results presented in Table 4, nine variables showed
statistically significant differences between adherent and non-adherent
patients (P<0.10). First, female patients were more likely than male
patients to adhere to treatment. Secondly, younger patients were more
likely to adhere to treatment than older patients. Thirdly, patients on
re-treatment were less likely to adhere to treatment. Fourthly, patients
who had to pay a fee to access health care services for diagnosis or treat-
ment were less likely to adhere to treatment. Fifthly, patients who
reported higher loss of income due to their illness were less likely to
adhere to treatment. Sixthly, patients who were away from home du-
ring treatment and patients from households including many migrant
workers were less likely to adhere to treatment. Non-adherence was
also more likely among patients who had spent some time in jail, this
indicator having been used here to approximate risk behaviours not
assessed in detail in the questionnaire (eg, alcohol and substance abuse).
Finally, non-adherence was also more likely among patients who re-
ported perceived stigmatisation (the stigma index is defined in Ap-
pendix 1).
Table 5 reports the results of the multiple logistic regression used
to determine the relative importance of various determinants of ad-
herence when controlling for the effect of other variables. The overall
model was statistically significant (P=0.059) and explained 44% of
observed differences in adherence. The dependent variable is dicho-
tomous: 1=adherence and 0=non-adherence. The independent vari-
ables in the model included a wide range of socio-demographic and
household characteristics of the patients, as well as variables approxi-
mating the determinants of adherence expounded in the quantitative
literature. After adjusting for possible confounding effects, a total of
eight variables featured as statistically significant determinants of
adherence (P<0.10). These include only two of the variables which
exhibited statistically significant differences between adherent and
non-adherent patients in Table 4. As was the case with the bivariate
analysis, the likelihood of adherence was higher where perceived stig-
matisation was lower. In addition, the likelihood of adherence was
significantly higher among patients who were not on re-treatment.
The results also point to the role played by the socio-economic cir-
cumstances of patients in explaining differences in adherence. Patients
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Marital status (married=1, single=2)
Years of education
Monthly household income (Rand)
Financial support received while on treatment (Rand)
Re-treatment patient (yes=1, no=0)
Paid to access treatment (yes=1, no=0)
Currently employed (yes=1, no=0)
Previously employed (yes=1, no=0)
Income loss due to illness (Rand)
Travel time to clinic (minutes)
Away from home during treatment (yes=1, no=0)
Number of migrants in household
Ever in jail (yes=1, no=0)
Able to eat before taking tablets (yes=1, no=0)




















































Sample (n)      170
LR Chi2 test (P)          33.17 (0.059)
Pseudo R2                           0.436
Note: Access to medical aid and piped water were excluded from the analysis, given that not one non-adherent
patient had access to medical aid and that all non-adherent patients had access to piped water. The experience
of side-effects was likewise excluded, given that these all non-adherent patients experienced these.
who had access to more financial support in the form of social grants,
a pension, remittance income, a salary or other income while on
treatment were more likely to adhere to treatment. Patients who
were usually able to eat before taking their tablets or who were mem-
bers of smaller households (which generally face relatively lower re-
source constraints) were also more likely to adhere to treatment. Em-
ployment status, moreover, posed a barrier to adherence, with pa-
tients who were currently employed being less likely to adhere to treat-
Table 5: Multiple logistic regression results: determinants of adherence
  
ment. Importantly, patients whose tablet-taking was supervised were
more likely to adhere to treatment. The association between adherence
and the TB knowledge index (defined in Appendix 1), although
statistically significant, did not exhibit the anticipated sign. One
would have expected the likelihood of adherence to increase in line
with the patient’s knowledge of TB. However, adherence was here as-
sociated with less knowledge of TB, which may reflect some spurious
correlation, given the relatively crude nature of the knowledge index
employed for this purpose (see Appendix 1).
3. Qualitative evidence on determinants of 
adherence
As stated earlier, the participants reported their ideas freely, and it
was easy for them to respond to the questions. All the questions
seemed relevant. However, despite the relaxed atmosphere during all
the FGDs, questions relating to side-effects of TB drugs, lack of
family support, and the stigma attached to the disease evoked much
stronger reactions from the participants than the other questions.
3.1 Knowledge of TB and educational campaigns
Mixed reactions concerning knowledge of TB emerged from the group
discussions. In most instances, participants who had had TB before,
and/or lived with a contact (someone who has TB), were more likely
to know what TB is, than those with no personal history of TB treat-
ment or any close contacts. However, further analysis reveals that the
participants’ understanding of TB was not always in agreement with
biomedical knowledge:
Female: Yes, I know what TB is all about. I have heard many people
talking about it. But for me, it is a family thing. It has been there
for some time in the family. I think I have inherited it from my pa-
rents ...
Male: My mother passed away while still taking TB treatment ... I
have [had] TB for the past three years despite having completed
treatment on all occasions. If you have TB you have got it, there is
nothing that can cure it. That is the way of this disease.
Concern was expressed about how one can become ill with TB
more than once (recurrent TB):
153
Matebesi & Booysen/Treatment adherence among tuberculosis patients
   
Male: I am really disappointed. I have been cured before, but no one
at the clinic can tell me why this disease keeps on coming back. The
only thing that I am told, is how to take my medication ...
Female: My grandmother first had TB. She has since passed away. I
was previously cured, but after six months, I became ill again. I was
sent to Santoord [TB hospital]. On my return, my brother was also
diagnosed with TB. He later also passed away ... this thing wants to
eat us all. Something has to be done. I really do not know why it
keeps on coming back.
Participants were also asked to mention any health information/
intervention campaigns that they knew of. Many participants men-
tioned nurses, doctors, radios, newspapers, television, family members,
and friends as their most important sources of information about TB.
Only a few were aware of TB health education activities in their areas.
3.2 Side-effects of drugs
When asked what factors led to non-adherence to the treatment re-
gimen, the reason most strongly emphasised by the majority of the
participants tended to be the physical side-effects of TB medication.
Another factor was the patient’s subjective negative experience with
the medication, which is not often communicated to health care pro-
viders, for fear of reprisal. The following quotations capture the feel-
ings cited by participants:
Male: These tablets let one’s body itches [sic] for the whole day. I
know someone who interrupted his treatment because of this pro-
blem. I told the nurses about the side-effects and they gave me other
tablets. But the problem is my situation is even worse now … I
console myself by rubbing myself with cabbage or orange bags.
Female: Since I have started taking this TB medication, my body is
full of pimples and sores. The rash is very painful. The nurses told
me that it is the nature of TB … the side-effects will go away with
time. The itching is bearable from Friday to Monday [treatment is
not taken over weekends]. But when we start taking treatment on
Monday, the irritation starts all over again … it seems as if these
tablets do not want you to stop taking them….
Female: … and when we report these side-effects, nurses will always
retort: ‘Hey you! You are a nuisance and childish, you have to expe-
rience side-effects because you have been drinking alcohol’, even if
that is not the case.
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3.3 Hunger and lack of family support
The majority of the patients who were employed at the time they be-
came ill mentioned that they had resigned or been dismissed. In most
cases these patients were breadwinners who not only had to face hos-
tile family members, but also a spell of hunger as a result of the me-
dication:
Male: The problem is that we have to come to the clinic every day
for medication. What is the role of the DOTS supporters? Some-
times we are tired … These tablets make you very hungry. Even
now I am hungry … Some patients may just decide to stay away
from the clinic if there is no food at home.
Female: We sometimes need to be pushed, but we do not get sup-
port from family members. These tablets are eating everything left
in your stomach. At times I really feel like not coming to the clinic.
Family members also seem to shun the company of patients in the
household:
Male: I have been afraid to tell them at home about my TB status.
Ever since they found out that I have TB, I have to cook my own
food in my tiny sleeping room. I have been instructed not to take
utensils that I use out of my room ... I am also not allowed to come
into close contact with the children ...
3.4 Stigma
The existing socio-cultural barriers and taboos associated with TB
have also been found to be major factors conducing to poor comple-
tion rates. This problem is exacerbated by the link between TB and
AIDS:
Male: I arrive early in the morning so that people could not see me.
I used to conceal my illness from people. It was only my mother and
wife who knew why am I am so often visiting the clinic. People
think that we are the filthiest people … it was really difficult to
accept that I have TB.
Female: If people can see you carrying your [treatment] card, they
will start to gossip about you. I have once overheard someone say-
ing, ‘Look at that beautiful girl who is carrying a TB card’. I used
to conceal the card in a brown envelope.
Male: Ever since I have been diagnosed with TB, my life has turned
upside down. My wife once packed all her belongings because she
told me I am dishonest about my status. She strongly believed that
I know I am infected with AIDS and not TB. Even if we can go now
  
to my place, you will detect that things are not OK between us …
I previously defaulted but realised it is not going to help.
It is evident that certain perceptions about TB not only contribute
to non-adherence, but also have the potential to discourage prospec-
tive patients from taking anti-TB drugs:
Female: There is a widespread perception in the community that
the very same TB tablets cause AIDS ...
3.5 Patient behaviour
It is interesting to note that participants did not only see factors out-
side their control as leading to non-adherence. Alcohol abuse by TB
patients, together with hours of clinic operation, were perceived to
be the most common reasons for non-adherence and treatment inter-
ruption:
Male: The clinic operation time is a hindrance. How would some-
one who starts drinking early in the morning visit the clinic? Some
patients consume alcohol daily. They would rather decide to inter-
rupt their treatment, rather than discarding their drinking habit.
Female: It is the third time that I am sick with TB. I used to drink
non-stop, from early in the morning till sunset ... This went on for
three months. Alcohol is really a big problem ...
Further, many participants mentioned the harm alcohol does to
the body. They explained that people who consume excessive amounts
of alcohol usually do not eat well. This weakens the body, which could
lead to other diseases. One participant said:
Male: If you do not eat, you give TB the power. If you eat well, it
will not affect you that badly. I know because I have also experi-
enced the negative impact of alcohol on one’s health.
The majority of the participants said that pure stubbornness is the
only reason why patients do not adhere to their treatment regimen.
Some participants indicated that in order for patients to adhere, they
need economic resources and certain personal resources, such as feel-
ing able to focus exclusively on the treatment plan.
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3.6 Health services factors
The following health services factors were mentioned as encouraging
non-adherence: the non-availability of TB medication at some cli-
nics, the attitude of health care providers, and the delay in diagnosis.
Participants commented:
Female: The biggest problem at this clinic is the non-availability of
treatment. There was a time when we did not receive treatment for
two weeks [showing card]. I marked my card in red in order to re-
member the days we did not get treatment. I really wanted to make
sure that my card was not being completed for treatment that I did
not receive. What are the stock control measures at this place? We
are being slowly murdered. [On inspection the card indicated that
the patient had not received medication for 13 days].
Male: Sometimes one finds it difficult to wake up because of tired-
ness. When you send someone to collect your medication at the
clinic, there is no co-operation from the nurses. They insist that one
has to come to the clinic irrespective of your circumstances …
Inasmuch as we understand that we had to come to the clinic, our
physical strength prevents us to do [sic] this at times ...
Participants reported having different experiences of the attitude
of health care providers:
Male: The attitude of nurses is also not helping the situation. When
you are in the waiting room, you will wait and wait and wait. Some-
times they are just sitting and chatting. The fewer they are in the
consultation room, the better. They also have a tendency to harass
TB patients in front of others.
Male: I have been treated well since I started my treatment at this
clinic. The nurses are very helpful. They treat us like their own
children ...
In terms of late diagnosis as a factor encouraging non-adherence,
participants reported that they would go three or four times to a
doctor before being diagnosed with flu. Some participants indicated
that doctors did not often inform them about the diagnosis: “They are
only interested in giving us injections”. More sadly, it was evident
that some of the participants had consulted various conventional health
care providers before being diagnosed with TB:
Female: I went to three different doctors. The first one told me I
have flu. The symptoms persisted, and after three days, I returned
to him. He gave me another injection. The second one did not even
bother to tell me what the problem was ... I vomited all the medi-
cation. It was only after the last doctor at the clinic sent me for X-
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rays, that I was diagnosed with TB ... The problem is you have to
pay R80.00 each time you consult a doctor.
3.7 What is needed to improve adherence?
In response to the question of what would improve adherence, parti-
cipants mentioned information provision, education and altering the
treatment plan. In particular, the majority of respondents felt that
TB health education campaigns should be provided from the same
“platform” as HIV/AIDS. They stressed that such campaigns should
focus on all members of society, and not only on TB patients. They
also felt that educational programmes, both in and out of school,
could influence pupils and students through the curriculum. They
further indicated that former TB patients could be used as ambassa-
dors of TB control initiatives, being invited to give speeches at church
and community gatherings.
The participants concluded that the treatment plan is too long.
There was also a strong feeling that more effective drugs, with fewer
side-effects, should be provided. The groups considered the services
provided by DOT supporters to be limited to the provision of medi-
cation. They believed that it would be beneficial to delegate more
responsibility (for the provision of information and health education)
to DOT supporters.
4. Discussion
Increased adherence is one of the main goals of any TB programme,
including the South African NTCP. Internationally, a range of stra-
tegies has been employed to improve adherence. Some of these are
aimed at changing the behaviour of health staff, eg by training, moti-
vation and supervision. Other strategies, in turn, are aimed at the pa-
tient, eg education, reminders and prompts for attendance, financial
incentives, supervision of tablet-taking and tracing defaulters (Vol-
mink & Garner 1997). Results from the quantitative and qualitative
research reported here suggest that several impediments still need to
be addressed in order to achieve this objective, in terms of both pro-
vider- and patient-related barriers to adherence. These impediments
present a potential invitation for health care authorities, managers
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and health care providers to play a greater role in the management
and treatment of TB patients. However, for rates of adherence to
improve in practice, patients’ views and any barriers to adherence need
to be understood, in order to implement appropriate interventions.
The evidence points to the role played by the socio-economic cir-
cumstances of patients in adherence. In fact, early research reported
that the strongest predictors of adherence were economic rather than
cognitive or cultural factors (Farmer 1997), a point of view shared by
Jaramillo (1999). Patients with access to more financial support while
on treatment were more likely to adhere to treatment, as were pa-
tients who were generally able to eat before taking their tablets. This
raises the question of whether incentives and enablers in the form of
food coupons or bus tokens could be employed to overcome certain
impediments to adherence (Buchanan 1997), especially for patients
from poor communities. According to Jaramillo (1999), poverty alle-
viation can play an important role in achieving tuberculosis control
in developing countries.
Other economic factors can also act as impediments to adherence.
The quantitative evidence shows that the likelihood of adherence is
lower among patients who are employed while on treatment or who
experience a significant loss of income due to treatment. Thorson
(2001) likewise reported that male patients, in particular, were likely
to interrupt their treatment due to work commitments. (Our own
results also found female patients more likely to adhere to treatment
than male patients, although gender was not a significant determi-
nant of adherence when the effect of other variables was controlling).
In addition, structural economic factors also seem to play a nega-
tive role in adherence, in particular the migrant labour system and
internal migration. Patients who were away from home during the
course of their treatment or from households including higher num-
bers of migrant workers were less likely to adhere to treatment (ie to
interrupt their treatment for two months or longer). According to
Kok et al (2002), the internal migration patterns operating in South
Africa in 1996 continued to mirror those of the apartheid era. Fur-
thermore, people who have been migrants are likely to continue to
migrate, given that “migration becomes institutionalised through the
formation and elaboration of networks” (Kok et al 2003: 26). This
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highlights the need to devise appropriate strategies for the successful
transfer of migrating patients from one health facility to another, so
as to ensure that they complete their treatment.
In the qualitative evidence reported here, TB patients were asked
to reflect on their own experiences. Most participants knew that TB
is a contagious disease, but some had an understanding of it which
deviated from biomedical knowledge. The mass media, nurses, family
members and friends were identified as their main sources of infor-
mation on TB. However, the majority of the participants were una-
ware of any health education activities concerning the disease in their
area. Metcalf (1991: 1) already noted more than a decade ago that
although TB is contagious, it has not yet ignited the same public
alarm as acute diseases such as HIV/AIDS.
Considering the profound effect that TB has on patients in terms
of effort and time — with some suffering for more than five years —
a key feature of the disease that became evident in this study is the
irritation that goes with the treatment. The side-effects described by
participants included bodily pain, pimples and sores. Some study re-
sults suggest that adherence rates may be adversely affected by
unreported side effects rather than by the amount of medication pre-
scribed. A study by Grant et al (2003) revealed that unreported side
effects and a lack of confidence in the immediate or future benefits of
treatment were significant predictors of sub-optimal adherence. It
was concluded that health care providers should not hesitate to pre-
scribe multiple agents in order to achieve adequate control of diseases
such as hypertension.
The pressing question with regard to TB treatment is: will patients
who have reported severe side-effects continue to take their medica-
tion? Gregson (2002: 461) states that, generally, treatments are aban-
doned not because they do not work well enough, but because they
are “too much trouble to take”. Imagine having to take TB treatment
for six months, mostly on an empty stomach, as it is the case for
many TB sufferers in South Africa. Clearly, adherence will be poor,
because most patients will choose to stay away from the clinic, rather
than taking tablets which lead to even worse hunger spells. The
studies of Schiffman & Zervakis’ (Doctors Guide 2000) on the taste
of drugs found that the innate desire to derive pleasure from tasting
    
food is so strong that people sometimes stop taking life-saving medi-
cation simply because it tastes bad or ruins the flavour of otherwise
enjoyable foods.
A study by Herman et al (2000: 74-5) showed that as treatment
regimens become more complex (swallowing between one and four
large tablets daily for six to eight months), it becomes more difficult
for patients to adhere to them. Some patients may fear that they will
develop a psychological or physical dependence on the medication. In
such instances health care providers may be viewed as unhelpful and,
as Kane (2002: ) states, as obstacles to a cure. The revelation that pa-
tients did not receive their medication for almost two weeks, because
it was not available at the clinics, gives cause for grave concern. Not
only the lives of already suffering patients were endangered, but such
a failure is also a huge blow to the government’s commitment to pro-
viding an uninterrupted supply of quality anti-TB drugs along with
sustained TB control.
Another notable finding was the roles played by stigma and by
social support, which featured in both the quantitative and qualita-
tive evidence as significant determinants of non-adherence. Studies
from the Philippines (Nichter 1994) and Vietnam (Johansson et al
1996; Long et al 2001) indicate that adherence is associated with
social support from family or others. The present study has shown that
participants’ families sometimes isolate them. One common form of
isolation, which was also noted by Long et al (2001), is the separation
of cooking utensils and bowls. The roles of stigma and social support
in influencing the outcomes of treatment for TB has been emphasised
by Liefooghe (2000) and Thorson (2001). According to Love (2002:
12), patients who live with supportive family members are more
likely to complete treatment. The present study has also shown the
need for a constructive family environment, which may increase the
amount of support and guidance available to patients. Stigmatisaton
is also reinforced by the required daily visits to primary health care
clinics. Liefooghe et al (1995), Long (2000) and Demissie et al (2003)
have also shown that the community tends to isolate many patients
and that adherence is affected by societal attitudes towards the disease.
Demissie et al (2003: 2009) report further that the TB club approach
to the delivery of treatment in rural North Ethiopia has had a “sig-
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nificant impact on adherence to treatment and in building positive
attitudes and practice in the community regarding TB”.8 Based on the
qualitative evidence, the association of TB with HIV/AIDS appears
to be the main source of stigmatisation. The physical appearance of
TB patients (slim body), which resemble that of AIDS patients, further
compounds stigmatisation. With high rates (52%) of TB-HIV co-
infection in the Free State (SATCI 2000: 14), the associated stigma
may lead to adverse treatment outcomes.
Participants in focus group discussions also perceived the illness
behaviour of patients as a factor encouraging non-adherence. Although
it is commonly known that poverty is an important risk factor for TB
globally (Long et al 2001:74), the present study has shown that TB
patients often abuse alcohol, which impedes their treatment adherence.
Evidence of this has also been reported by Pablos-Méndez (1997),
Malotte et al (2001) and Hovell et al (2003). In fact, the South African
Demographic and Health Survey of 1998 (Dept of Health 2002b:
238) indicates that 28% (n=8.3 million) of South Africans aged 15
years and older consume alcohol.
The health care provider-patient relationship has been shown to
be an important determinant of adherence (Zwarenstein et al 1998;
Vermeire et al 2001; Jaiswal et al 2003). Health care providers at cli-
nics are an essential link between the programme and the patients,
being responsible for providing treatment and maintaining registers.
From the point of view of control, informed, motivated frontline
health workers may contribute positively to treatment outcomes. Con-
versely, demotivated or ill-informed health workers may encourage
patients to interrupt treatment and thus to further transmission of
TB in affected communities. This study has revealed some important
dysfunctional aspects of the attitudes of health care providers to TB
8 TB patients from a single village are organised into “clubs” of 3 to 10 patients
by the local health-care worker. The members of each TB club have the same
clinic dates for follow-up. The leader of the club ensures that all members
attend the TB clinic and informs the clinic staff about absent members. In ad-
dition, TB clubs have both regular and ad hoc meetings at which they support
each other and share their experiences of the disease with fellow members. The
leaders of these clubs also solicit the help of community leaders to encourage
patients to complete their treatment (Demissie et al 2003: 2012).
                
patients. According to Stein (2000), non-adherence may result from
differing degrees of interest or expectation between the patient and
the health care provider. Misperceptions or dissatisfaction with the
relationship between the patient and the health care provider may
also cause non-adherence.
The evidence presented in this study also reinforces the importance
of the traditional key component of DOTS — the direct supervision
of tablet-taking. Patients whose tablet-taking was supervised were
more likely to adhere to treatment, all other things being equal. Su-
pervised tablet-taking will thus remain a key component of the DOTS
strategy to improve adherence and cure rates, given the increasing evi-
dence of the role of such supervision in enhancing adherence (Jaramillo
1999; Chaisson et al 2001).
Finally, and perhaps most importantly, the quantitative evidence
shows that patients undergoing re-treatments are less likely to adhere
to treatment than those undertaking it for the first time, thus high-
lighting the role of non-adherence in exacerbating the MDR problem
in South Africa. Hence, particular care needs to be taken to address
the impediments to adherence mentioned above among patients un-
dergoing re-treatment.
5. Conclusion
Non-adherence to treatment regimens poses a major challenge to TB
patients, their families and the health care community. It results in
poor treatment outcomes and increased costs. The evidence reported
here highlights the fact that adherence is a function not only of the
quality and availability of health care, but also of a variety of per-
sonal, socio-economic, infrastructural and community-related factors.
Apart from alleviating poverty in an attempt to break down the socio-
economic barriers to adherence, raising public awareness about the
importance of making the lifestyle modifications which can prevent
TB, and organising widespread dissemination of accurate information
about the causes, prevention and health management of the disease
may counter the myths and misconceptions surrounding it. In order
to enhance patient adherence rates, TB control programmes in resource-
poor settings such as the Free State province need to take cognisance
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of the dysfunctional behaviour of health care providers, close contacts
and TB patients. Patients should be encouraged to report the diffi-
culties they face, rather than being afraid of being victimised. In this
regard, the training of health care providers involved with TB at the
primary level should incorporate aspects relating to patient behaviour.
This study has revealed some important factors which encourage
non-adherence. Regarding the attitude of health care providers, ex-
panded training in communication skills and optimal patient care,
according to treatment guidelines, are needed, particularly in the light
of the emergence of multi-drug-resistance TB. Such training should
focus not only on nurses, but also on doctors. It is highly unlikely that
effective short-term chemotherapy will be widely available in South
Africa, or in the world, in the next ten years. Thus, behavioural change
remains a viable means of improving treatment adherence and limit-
ing the spread of infection. Studies around the world have shown that
behavioural interventions such as health education can bring about a
reduction in high-risk behaviour. The continuing increase in TB in-
fection rates in South Africa suggests that health education, dissemi-
nation of information and attempts at communication have been either
limited or not effective on a broad enough scale to achieve significant
public impact. It is therefore recommended that current education pro-
grammes on TB should be revised by the South African Tuberculosis
Control Programme in order to overcome the most important barriers
relating to treatment adherence. More sustained health education
campaigns should also be directed towards patients, their close contacts,
health care providers and the community at large.
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Marital status (married=1, single=2)
Years of education
Monthly household income (Rand)
Financial support received while on treatment (Rand)
Re-treatment patient (yes=1, no=0)
Paid to access treatment (yes=1, no=0)
Currently employed (yes=1, no=0)
Previously employed (yes=1, no=0)
Income loss due to illness (Rand)
Travel time to clinic (minutes)
Away from home during treatment (yes=1, no=0)
Number of migrants in household
Ever in jail (yes=1, no=0)
Able to eat before taking tablets (yes=1, no=0)











Access to medical aid (yes=1, no=0)
Main breadwinner (yes=1, no=0)
Access to piped water in dwelling (yes=1, no=0)
Side-effects experienced (yes=1, no=0)
4.025 - 4.6484.337 0.158
1.379 - 1.5241.451 0.037
36.38 - 39.6638.022 0.832
1.543 - 1.6851.614 0.036
7.342 - 8.3327.837 0.251
1 065 - 1 3611 213.641 75.079
356.9 - 578.7467.891 56.212
0.018 - 0.0810.049 0.016
0.242 - 0.3770.310 0.034
-0.004 - 0.0260.011 0.008
0.304 - 0.4460.375 0.036
0.273 - 0.4120.342 0.035
0.095 - 0.1980.147 0.026
881.7 - 3 212.42 047.120 590.654
22.38 - 28.8625.626 1.642
0.055 - 0.1420.098 0.022
0.071 - 0.1730.122 0.026
0.063 - 0.1540.109 0.023
0.878 - 0.9580.918 0.020
0.771 - 0.8810.826 0.028
0.871 - 0.9540.912 0.021
0.984 - 1.0050.995 0.005
2.094 - 2.4372.265 0.087
0.171 - 0.3390.255 0.043
5.039 - 5.3085.174 0.068
1.538 - 1.7231.630 0.047






























Notes: The crowding index was calculated by dividing the average household size by the number of rooms in
which to sleep. The stigma index represents the number of times the patient indicated that the general
reaction of his spouse/partner, family members, friends, community members, or neighbours, employer and
co-workers, on learning about his/her illness, was negative or constituted rejection. The tuberculosis knowledge
index represents the number of times the patient disagreed or strongly disagreed with the statement that one
can stop taking TB medication when one feels better as well as the number of times the patient agreed or
strongly agreed with the statements that (a) someone with TB who is not on treatment can infect other people,
(b) TB can be cured, (c) TB affects men, women and children, (d) people living with a TB patient also need
to be examined, (e) TB could be a symptom of HIV/AIDS. The service quality index represents the average
score out of 5 on six questions related to the satisfaction of the patient with (a) the distance to the clinic,
(b) the waiting time before he/she was helped, (c) the general appearance of the clinic, (d) the support or
friendliness of clinic staff, (e) the amount of time health care workers spent with the patient during his/her
consultation, and (f) the examination of illness.
          
166
Acta Academica 2004: 36(3)
Bibliography
ALBRECHT G L, R FITZPATRICK & 
S C SCRIMSHAW (eds)
2000. The handbook of social studies
in health & medicine. London: Sage.
BAMFORD L
1999. Tuberculosis. South African
Health Review 1999. Durban:
Health Systems Trust: 315-30.
BIRD F, P CONRAD & A M FREMONT
(eds)
2000. Handbook of medical sociology.
5th ed. Englewood Cliffs, New
Jersey: Prentice-Hall.
BUCHANAN R J
1997. Adherence with tuberculosis
drug regimens: Incentives and
enablers offered by public health
departments. American Journal of
Public Health 87(12): 2014-7.
CHAISSON R E, G L BARNES, 
J HACKMAN, L WATKINSON, 
L KIMBROUGH, S METHA, S CAVAL-
CANTE & R D MOORE
2001. A randomized, controlled
trial of interventions to improve
adherence to isoniazid therapy to
prevent tuberculosis in injection
drug users. American Journal of
Medicine 110: 610-5.
COCKERHAM W C
2001. The Blackwell companion to
medical sociology. Malden, Mass:
Blackwell.
COLLINS T F B
1992. The prevention of tuberculo-
sis. Help yourself to better health:
A community-oriented project.
Educamus 38(5): 26-7.
COOVADIA H M & S R BENATAR
(eds)
1991. A century of tuberculosis: South
Africa perspectives. Oxford: Oxford
University Press.
DANUSANTOSO H
2002. Bridging the TB treatment
gap. <http://www.stoptb.org>
DEMISSIE M, H GETAHUN & 
B LINDTJØRN
2003. Community tuberculosis
care through ‘TB clubs’ in rural
North Ethiopia. Social Science &
Medicine 56: 2009-18.
DEPARTMENT OF HEALTH, RSA
2001. The South African Tuberculosis
Control Programme: practical guide-
lines 2000. Pretoria: Dept of
Health.
2002a. Tuberculosis in South
Africa, 1998-2001. Newsletter from
the National HIV/AIDS and TB
Programme 25: 1-5.
2002b. The South African Demogra-
phic and Health Survey 1998.
Pretoria: Dept of Health.
DICK J
1994. Adherence to anti-tuberculosis
therapy in Cape Town. Unpubl
PhD in Community Health. Cape
Town: University of Cape Town.
                          
167
Matebesi & Booysen/Treatment adherence among tuberculosis patients
DOCTORS’ GUIDE
2000. Bad taste of drugs may
affect treatment adherence, study
findings suggest. <http://www.psl
group.com/dg/195296.htm>
ENARSON D A, H L RIEDER, 
T ARNADOTTIR & A TRÈBUQ
2000. Management of tuberculosis: a
guide for low income countries. Paris:
International Union Against
Tuberculosis and Lung Disease.
FARMER P
1997. Social scientists and the new
tuberculosis. Social Science & Medi-
cine 44(3): 347-58.
GARCIA-GARCIA M L, A PONCE-DE-
LEÓN, M C GARCÍA-SANCHO, L
FERREYRA-REYES, M PALACIOS-
MARTÍNEZ, J FUENTES et al
2002. Tuberculosis-related deaths
within a well-functioning DOTS




GIUFFRIDA A & D J TOGERSON
1998. Should we pay the patient?
Review of financial incentives to
enhance patient adherence. British
Medical Journal SA 6: 186-90.
GOVERNMENT OF SOUTH AFRICA




1999. The global burden of
tuberculosis. Portert & Grange
(eds) 1999: 3-24.
GRANT R W, N G DEVITA, 
D E SINGER & J B MEIGS
2003. Polypharmacy and medica-
tion adherence in patients with
type 2 diabetes. Diabetes Care 26:
1408-12.
HOVELL M, G E BLUMBERG, 
L GILTREJO, A VERA, N KELLEY, 
C SIPAN, C R HOFSTETTER, 
S MARSHALL, J BERG, L FRIEDMAN,
A CATARANZO & K MOSER
2003. Predictors of adherence to
treatment for latent tuberculosis
infection in high-risk Latino ado-
lescents: a behavioral epidemi-




with prevention: the path for a
lasting control of tuberculosis.
Social Science & Medicine 49: 393-
404.
JAISWAL A, V SINGH, J A OGDEN, 
J D H PORTER, P P SHARMA, 
R SARIN, V K ARORA & R C JAIN
2003. Adherence to tuberculosis
treatment: lessons from the urban
setting of Delhi, India. Tropical
Medicine and International Health
8(7): 625-33.
                    
168
Acta Academica 2004: 36(3)
JOHANSSON E, V K DIWAN, 
N D HUONG & B M AHLBERG
1996. Staff and patient attitudes to
tuberculosis and adherence with
treatment: an exploratory study in
a district in Vietnam. Tubercle and
Lung Disease 77: 178-83
KANE J M




KERR N L, J ARONOFF & L A MESSE
2000. Methods of small group
research. Reis & Judo (eds) 2000:
160-89.
KHAN A, J WALLE, J NEWELL & 
N IMDAD
2000. Tuberculosis in Pakistan:
socio-cultural constraints and
opportunities in treatment. Social
Science and Medicine 50: 247-54.
KOK P, M O’DONOVAN, O BOUARE
& J VAN ZYL
2003. Post-apartheid patterns of
internal migration in South Africa.
Cape Town: Human Sciences
Research Council.
KOLA E F
2001. Health and socio-demographic
influences on selection of health care
providers. Ann Arbor, Michigan:
University of Michigan.
LERNER B H
1997. From careless consumptives
to recalcitrant patients: the historical
construction of non-adherence. So-
cial Science & Medicine 45(9): 1423-31.
LIEFOOGHE R
2000. The human dimension in
TB control: myth or reality.
Meulemans (ed) 2000: 41-56.
LIEFOOGHE R, N MICHIELS, 
S HABIB, M B MORAN & A DE
MUYNCK
1995. Perception and social conse-
quences of tuberculosis: a focus
group study of tuberculosis patients
in Sialkot, Pakistan. Social Science &
Medicine 41: 1685-992.
LONG N H
2000. Gender specific epidemi-
ology of tuberculosis in Vietnam.
Unpubl PhD in Community
Health. Stockholm: Karolinska
Institute.
LONG N H, E JOHANSSON, 
V K DIWAN & A WINKVIST
2001. Fear and social isolation as
consequences of tuberculosis in
Vietnam: a gender analysis. Health
Policy 58: 69-81.
LOVE R C
2002. Strategies for increasing
treatment adherence: the role of
long-acting antipsychotics. Ameri-
can Journal of Health-System Phar-
macy 59: 10-5.
MALOTTE C K, J R HOLLINGSHEAD
& M LARRO
Date?. Incentives versus outreach
workers for latent tuberculosis
treatment in drug users. American
Journal of Preventive Medicine 20(2):
103-7.
                    
169
Matebesi & Booysen/Treatment adherence among tuberculosis patients
MATA J I
1985. Integrating the client’s per-
spective in planning a tuberculosis
education and treatment program
in Honduras. Medical Anthropology
Winter: 57-64.
MEULEMANS H (ed)
2000. Tuberculosis in Pakistan: The
forgotten plague. Leuven: Acco.
MEULEMANS H, D MORTELMANS, R
LIEFOOGHE, P MERTENS, S A ZAIDI,
M F SOLANGI & A DE MUNCK
2000. The limits to patient adhe-
rence with Directly Observed
Therapy for tuberculosis. Meule-
mans (ed) 2000: 73-93.
MIROWSKY J, C E ROSS & 
R REYNOLDS
2000. Links between social status
and health status. Bird et al (eds)
2000: 47-67.
NEEDHAM D M, S D FOSTER, 
G TOMLINSON & P GODFREY-
FAUSSETT
2001. Socio-economic, gender and
health services factors affecting
diagnostic delay for tuberculosis
patients in urban Zambia. Tropical
Medicine and International Health
6(4): 256-9.
NGAMVITH J, A WINKVIST & 
V DIWAN
2000. High AIDS awareness may
cause tuberculosis patient delay:
results from an HIV epidemic area,
Thailand. AIDS 14: 1413-9.
NICHTER M
1994. Illness semantics and inter-
national health: The weak lung/TB
complex in [the] Phillipines. Social
Science & Medicine 38: 649-63.
OLLE-GOIG J E
2000. Patients with tuberculosis in
Bolivia: why do they die? Revista
Panamericana de Salud Pública 8(3):
151-5.
PABLOS-MÉNDEZ A, C A KNIRSCH,
R G BARR, B H LERNER & 
T R FRIEDEN
1997. Non-adherence in tubercu-
losis treatment: predictors and
consequences in New York City.
American Journal of Medicine 102:
164-70.
PACKARD R M
1991. Holding back the tide: TB
control efforts in South Africa.
Coovadia & Benatar (eds) 1991:
43-57.
PORTERT J D H & M GRANGE (eds)
1999. Tuberculosis: an interdiscipli-
nary perspective. London: Imperial
College.
PRICE B
1996. Illness careers: the chronic
illness experience. Journal of
Advanced Nursing 24: 275-9.
REIS H T & C M JUDO (eds)
2000. Handbook of research: methods
in social and personality psychology.
New York: Cambridge University
Press.
                        
170
Acta Academica 2004: 36(3)
RIEDER H L
2002. Interventions for tuberculosis
control and elimination. Paris: Inter-
national Union Against Tubercu-
losis and Lung Disease.
RUBEL A J & L A GARRO
1992. Social and cultural factors in
the successful control of tubercu-
losis. Public Health Reports 107:
626-36.
SIEGRIST J
2000. The social causation of




2000. Tuberculosis: defying a common
foe. Pretoria: Southern African
Development Community.
STATISTICS SOUTH AFRICA
2002. Causes of death in South
Africa: advance release of recorded
deaths. Pretoria: Statistics South
Africa.
STEIN R W
2000. Non-adherence in the




1998. Tuberculosis: a deadly
epidemic out of control. World
Socialist Web Site. International
Committee of the Fourth Inter-
national. <http://www.wsws.org/
news/1998/dec1998/tb-d11.shtml>
THORSON A & W K DIWAN
2001. Gender inequalities in
tuberculosis: aspects of infection,
notification rates, and adherence.
Current Opinion in Pulmonary
Medicine 7: 165-9.
VAN RENSBURG H C J, A FOURIE
& E PRETORIUS
1992. Health care in South Africa:
structure and dynamics. Pretoria:
Academica.
VERMEIRE E, H HEARNSHAW, P
VAN ROYEN & J DENEKENS
2001. Patient adherence to treat-
ment: three decades of research. A
comprehensive review. Journal of
Clinical Pharmacy and Therapeutics
26: 331-42.
VISSER P S, J A KROSNICK & 
P J LAVRAKAS
2000. Survey research. Reis & Judo
(eds) 2000: 223-52.
VOLMINK J & P GARNER
1997. Systematic review of
randomised controlled trials of
strategies to promote adherence to
tuberculosis treatment. British
Medical Journal 315: 1403-6.
VOLMINK J, P MATCHABA & 
P GARNER
2000. Directly observed therapy
and treatment adherence. The
Lancet 355: 1345-50.
                      
171
Matebesi & Booysen/Treatment adherence among tuberculosis patients
WILKINSON D, S BECHAN, 
C CONNOLLY, E STANDING & 
M SHORT
2002. Should we take a history of
prior treatment, and check sputum
at 2-3 months when treating pa-




2001. Outcomes management: applica-




2001. Global Tuberculosis Control.
Geneva: WHO Report.
ZWARENSTEIN M, J H SCHOEMAN,
C VUNDULE, C J LOMBARD & 
M TATLEY
1998. Randomised controlled trial
of self-supervised and directly
observed treatment of tuberculosis.
The Lancet 352: 1340-3.
        
